APA

Koutsouraki E., Hatzifilipou E., Michmizos D., Cotsavasiloglou C., Costa V. & Baloyannis S. (20120510). Increase in interleukin-6 levels is related to depressive phenomena in the acute (relapsing) phase of multiple sclerosis. : The Journal of neuropsychiatry and clinical neurosciences.

Chicago

Koutsouraki Euphrosyni, Hatzifilipou Eleni, Michmizos Dimitrios, Cotsavasiloglou Christos, Costa Vassiliki and Baloyannis Stavros. 20120510. Increase in interleukin-6 levels is related to depressive phenomena in the acute (relapsing) phase of multiple sclerosis. : The Journal of neuropsychiatry and clinical neurosciences.

Harvard

Koutsouraki E., Hatzifilipou E., Michmizos D., Cotsavasiloglou C., Costa V. and Baloyannis S. (20120510). Increase in interleukin-6 levels is related to depressive phenomena in the acute (relapsing) phase of multiple sclerosis. : The Journal of neuropsychiatry and clinical neurosciences.

MLA

Koutsouraki Euphrosyni, Hatzifilipou Eleni, Michmizos Dimitrios, Cotsavasiloglou Christos, Costa Vassiliki and Baloyannis Stavros. Increase in interleukin-6 levels is related to depressive phenomena in the acute (relapsing) phase of multiple sclerosis. : The Journal of neuropsychiatry and clinical neurosciences. 20120510.